Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Lilly Opens Labs In California
by Rick Mullin
November 9, 2009
| A version of this story appeared in
Volume 87, Issue 45
In a move to advance its biotech drug pipeline, Eli Lilly & Co. opened a new biotechnology center in San Diego last week. The 113,000-sq-ft facility will accommodate 200 scientists from Lilly’s Applied Molecular Evolution protein-based therapy subsidiary and its discovery chemistry research and technology division. Tom Bumol, head of the new center, says the two divisions are combining forces to break new ground in biologic therapies for cancer, diabetes, and autoimmune diseases.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter